QA: Agile Therapeutics INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001261249_2020_Agile_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001261249, Agile Therapeutics INC

  xvar xval
0 AssetsCurrent 35,319,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 14,044,000
3 remainder_Assets 177,000
4 LiabilitiesCurrent 3,795,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,027,604
9 ResearchAndDevelopmentExpense 9,911,839
10 remainder_Expenses -72,263
11 remainder_Revenues 0
12 remainder_NetIncome -163,585
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 49,540,000
1 Liabilities 3,795,000
2 Expenses 18,867,180
3 Revenues 0
4 StockholdersEquity 45,745,000
5 NetIncome -19,030,765
6 ComprehensiveNetIncome -19,030,765
7 BaseVar 36,182,882
8 EconomicCapitalRatiobeforeLimitedLiability 3.03
9 EconomicCapitalRatio 3.70

Edgar->Model Mapping

Feature Distribution

Change over Time